Product Reports Resources Pricing Login Book a demo

SAGE Therapeutics

Biotech & Life Sciences · Raleigh, United States · Founded 2010 · IPO 2014

Develops and delivers novel medicines for most debilitating and disabling central nervous system disorders

Valuation $191M
Revenue $70M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue
Featured in
News Tortugas Neuroscience launches with $106M for mid-stage CNS pipeline Apr 21, 2026

Investors

6 investors on SAGE Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Third Rock Ventures
Series B+ 5 investors entered at this stage
ARCH Venture Partners
Washington University in St. Louis
Foresite Capital
OrbiMed
EcoR1 Capital

SAGE Therapeutics mafia

Startups founded by SAGE Therapeutics alumni

Former SAGE Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.

Praxis Precision MedicinesEst. 2015
Kiran ReddyUnited States
Signal score95
Model MedicinesEst. 2019
SRSean RussellUnited States
Signal score78
Voyager TherapeuticsEst. 2014
Steven PaulUnited States
Signal score66
Nido BiosciencesEst. 2018
Jamil BegUnited States
Signal score61
Tortugas NeuroscienceEst. 2024
Albert J. RobichaudUnited States
Signal score58

Book a demo to explore the full alumni network →

Global footprint

Where SAGE Therapeutics has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States97.5%
🇬🇧 United Kingdom1%
🇨🇦 Canada0.7%
🇪🇬 Egypt0.4%
4 countries shown
Web traffic by country
4.8K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

Talent graph

The shape of SAGE Therapeutics's talent

Dealroom maps SAGE Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

31 standout operatorsDealroom-flagged across the org
6 AI specialistspinpointed by name
193 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock SAGE Therapeutics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$273M patent portfolio · 124 active families

Estimated portfolio value
$273M
143.0% of market cap · 21.1× smaller than top peer Ablynx ($5.8B)
124 active patent families
Where SAGE Therapeutics innovates Autism disorderAutism spectrum disorderDiseaseMedicinal chemistryNeuroactive steroid

Where SAGE Therapeutics concentrates vs peers

Each axis is a top-10 topic across SAGE Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about SAGE Therapeutics

An AI-synthesized read of the highest-engagement posts about SAGE Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SAGE Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles